The USR antigen is composed of Venereal Disease Research Laboratory (VDRL) antigen containing choline chloride, which serves to block interfering substances in the serum (4, 5) and thus eliminates the heating of the serum before testing. The antigen has been stabilized with EDTA, thereby eliminating the necessity of daily antigen preparation and the attendant variations that could occur in the VDRL test as a result of this variable. The USR test is very similar in appearance to the VDRL test in that reactivity in both tests is gauged by the size of flocculation particles which are examined microscopically. The USR and VDRL tests are also similar in that the degrees of reactivity are reported in the same manner, i.e., nonreactive, weakly reactive, and reactive.
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In this study, the tests used for comparison with the USR test were the VDRL slide and the rapid plasma reagin (RPR) (1) To evaluate the use of the USR test on routine specimens, 360 frozen sera were obtained from the CDC Venereal Disease Serum Bank (group II), and 120 fresh sera were obtained from a local county sexually transmitted disease clinic (group III). All sera were categorized by stages of syphilis. The criteria for classifying a serum as false-positive were: (i) reactivity in at least one of the three nontreponemal tests; and (ii) a nonreactive fluorescent treponemal antibody absorption result. In addition, four sera from the serum bank were tested 15 times each as a means of establishing the repeatability of the quantitative test. These sera were coded and randomly entered into testing each The USR test was performed quantitatively by diluting the serum on paraffin-ringed glass slides with IL, RPR, and 0.9o saline. A 0.05-ml drop of 0.9% saline was placed All reagents in all but the first ring of the titration with a microtitrared from the tion dropper. A 0.05-ml drop of serum was placed in ie tests were the first and second rings, thereby resulting in a 1:2 dilution in the second ring. Twofold dilutions were performed with a pipetting device with disposable plastic tips. 
RESULTS
The titers of the 315 sera in group I, which consisted of patients whose treatment schedules were followed, were examined in the VDRL, RPR card, and USR quantitative tests. Of the successfully treated cases, i.e., with no Excluding those sera which were either nonreactive in one of the two tests compared or which gave equivocal weak reactions in the USR or VDRL test, the overall agreement ± 1 dilution of the 795 sera tested was 71.3% (357/501 reactive by both tests) between the VDRL and RPR tests (Fig. 2) , 84.4% (421/499 reactive by both tests) between the USR and RPR tests (Fig. 3) , and 87.3% (420/481 reactive by both tests) between the USR and VDRL tests (Fig. 4) In the repeatability study ( 
